GM Advisory Group’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.3M Buy
75,402
+20
+0% +$1.64K 0.24% 55
2025
Q4
$6.91M Sell
75,382
-8,375
-10% -$802K 0.27% 55
2025
Q3
$7.94M Hold
83,757
0.34% 50
2025
Q2
$8.77M Hold
83,757
0.43% 46
2025
Q1
$7.4M Hold
83,757
0.4% 46
2024
Q4
$8.04M Sell
83,757
-5,256
-6% -$490K 0.44% 45
2024
Q3
$7.29M Hold
89,013
0.44% 46
2024
Q2
$7.67M Sell
89,013
-39
-0% -$3.15K 0.5% 41
2024
Q1
$7.27M Sell
89,052
-31,303
-26% -$2.44M 0.51% 35
2023
Q4
$7.98M Buy
120,355
+90,329
+301% +$6.26M 0.6% 30
2023
Q3
$2.19M Buy
+30,026
New +$2.03M 0.18% 51

Other funds holding HQY

GM Advisory Group's HQY Position: Q1 2026 in Review

GM Advisory Group increased its HealthEquity (HQY) stake by 0.03% in Q1 2026, buying an estimated $1.64K and bringing the position to 75,402 shares worth $6.3M. The position accounts for 0.24% of the portfolio, ranked #55.

GM Advisory Group first reported a position in HQY in Q3 2023 and has held it in 11 quarters since. The position peaked at $8.77M in Q2 2025. 487 funds tracked by Wall St. Rank hold HQY as of Q1 2026.

  • GM Advisory Group held 75,402 shares of HealthEquity worth $6.3M as of Q1 2026.
  • GM Advisory Group bought 20 HealthEquity shares in Q1 2026, an estimated $1.64K.
  • HealthEquity made up 0.24% of GM Advisory Group's portfolio in Q1 2026, its #55 holding.
  • GM Advisory Group first reported a position in HealthEquity in Q3 2023 and has held it in 11 quarters since.
  • GM Advisory Group's HealthEquity position peaked at $8.77M in Q2 2025.
  • 487 funds tracked by Wall St. Rank held HealthEquity as of Q1 2026.

Based on GM Advisory Group's 13F filing for Q1 2026, filed 28 Apr 2026.